Fri.Jun 23, 2023

article thumbnail

Senate Introduces Bill to Combat High Pharmacy DIR Fees

Drug Topics

The Protect Patient Access to Pharmacies Act will help to secure Medicare patients’ freedom to receive medications and care from the pharmacy of their choice.

469
469
article thumbnail

STAT+: Two type 1 diabetes patients now freed from insulin shots with cell therapy, Vertex reports

STAT

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.  The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moderna Files for FDA Authorization of Updated COVID-19 Vaccine

Drug Topics

Pending authorization of the XBB.1.5 vaccine, the company said that doses would be available in time for fall vaccination.

Vaccines 247
article thumbnail

Innovation is Necessary to Preserve Independent, Community Pharmacy

Pharmacy Times

Pharmacists can recognize evidence of successful interventions and learn how to integrate them into their own practice.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

First Gene Therapy to Treat Pediatric Duchenne Muscular Dystrophy Approved by FDA

Drug Topics

The accelerated approval of delandistrogene moxeparvovec-rokl is “based on expression of Elevidys micro-dystrophin observed in patients treated with ELEVIDYS,” according to Sarepta Therapeutics.

FDA 247
article thumbnail

Generative Health: A new standard of care

pharmaphorum

Generative Health: A new standard of care Mike.

130
130

More Trending

article thumbnail

STAT+: GSK settles first lawsuit set for a U.S. trial over cancer links to Zantac

STAT

GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such case that was about to go to trial in the U.S. In a brief statement , the company disclosed that it reached a settlement with James Goetz, who filed a lawsuit in a California state court. The deal reflected its desire “to avoid distraction related to protracted litigation in this case.

129
129
article thumbnail

AWS launches generative AI center backed by $100M investment

Fierce Healthcare

Amazon Web Services launched a new innovation center focused on generative AI backed by a $100 million investment, its most recent bid to keep up with the AI race. | Amazon's cloud unit launched the AWS Generative AI Innovation Center with a $100 million investment, its most recent bid to keep up with the AI race.

127
127
article thumbnail

Defining Indolent Relapse Multiple Myeloma

Pharmacy Times

Dr Haumschild opens the discussion with Larry Anderson, MD, PhD, and Gabe Hinojosa, PharmD, BCOP, regarding various states of relapse in multiple myeloma.

123
123
article thumbnail

Psylo signs research deal with Daiichi Sankyo for psychiatric therapies

Pharmaceutical Technology

Psylo and Daiichi Sankyo have signed a sponsored research deal to advance the development of non-hallucinogenic psychiatric therapies.

119
119
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharmacy Technicians With Community Health Worker Training Can Improve the Value of The Pharmacy in Health Care

Pharmacy Times

Community health workers can address issues of health equity to enhance the services of the pharmacy and support a value-based care model.

123
123
article thumbnail

How a six-in-one vaccine could soon help the world get rid of polio for good

STAT

Polio eradication is a delicate dance. And one of the biggest challenges facing the people trying to choreograph its final steps is how to phase out use of oral polio vaccines. The oral vaccines have brought the paralyzing viruses to the brink of  annihilation; so far this year there have only been six cases detected, five in Afghanistan and one in Pakistan.

Vaccines 115
article thumbnail

Lung Cancer Symptoms and Treatment Options

Pharmacy Times

Approximately every 2.2 minutes, a new diagnosis of lung cancer is registered.

123
123
article thumbnail

Gaps in breast cancer care in Europe and the importance of genomic testing

pharmaphorum

Gaps in breast cancer care in Europe and the importance of genomic testing Mike.

115
115
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Differentiating Treatment Strategies for Indolent Versus Aggressive Relapse MM

Pharmacy Times

Medical experts discuss treatment options for indolent and aggressive relapse multiple myeloma.

123
123
article thumbnail

AI in healthcare

pharmaphorum

AI in healthcare Mike.

111
111
article thumbnail

Study: 10% of NHS Health Care Workers Experienced Suicidal Thoughts During COVID-19 Pandemic

Pharmacy Times

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

122
122
article thumbnail

STAT+: Lilly’s obesity pill cuts 15% of weight at highest dose in mid-stage trial

STAT

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy. The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full   results,  published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the Americ

106
106
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Industry Voices—Hospitals can't lose sight of infection control as COVID recedes

Fierce Healthcare

The need for capable healthcare staff was an urgent concern for me as my surgery for a major medical condition was placed on hold. | Unless we commit to a reliable and robust measurement system of hospital-acquired infections, we will continue to have a stressed workforce and need to rely on data generated in other countries.

Hospitals 106
article thumbnail

CandyRific releases Disney100 limited-edition dispensers, candy cases

Drug Store News

The Disney100 Collectible candy dispensers and Disney Mickey Mouse and Minnie Mouse gift set will be ready for shipping in late summer/early fall.

106
106
article thumbnail

STAT+: Using its Covid know-how, Color Health aims to make cancer screenings convenient

STAT

Color Health wants to take away any reason you might have for skipping screenings for cancer.  The Silicon Valley company, which pivoted from cancer genomics to Covid-19 testing on a large and hugely profitable scale, has a new program that incorporates both its roots in cancer testing and its logistical experience from the pandemic. Called, simply, the Cancer Prevention and Screening Program, and built in partnership with the American Cancer Society, the program aims to make it easy to get

Insurance 104
article thumbnail

Optum adding 2 more Humira biosimilars to its formulary

Fierce Healthcare

Optum Rx will add two more Humira biosimilars to its formulary later this summer. | Optum Rx will add two more Humira biosimilars to its formulary later this summer.

100
100
article thumbnail

Opinion: The staggering financial burden of giving birth — even with insurance

STAT

The burden of high health care costs and medical debt in the U.S. is no secret. Medical debt affects one in five adults in the U.S., with an average burden of more than $20,000 for each medical debtor. As primary care physicians, we frequently witness the effects of these financial burdens, particularly for our older or sicker patients with expensive medical conditions.

Insurance 101
article thumbnail

First RNA CAR-T therapy autoimmunity trial shows potential

European Pharmaceutical Review

Study data from a major trial has demonstrated RNA CAR-T (rCAR-T) therapy Descartes-08 facilitated significant and long-lasting clinical improvement in generalised myasthenia gravis (gMG). This is the first clinical trial using rCAR-T to treat autoimmunity. It is also the first successful Phase II trial using an engineered cell therapy for autoimmunity.

article thumbnail

New research underscores benefits of gender-affirming hormones, rebutting anti-trans claims

STAT

Anti-trans legislation and rhetoric frequently suggest that taking gender-affirming hormones is a big health risk. But at the annual meeting of the Endocrine Society last week, researchers presented swaths of evidence on the benefits of gender-affirming hormones and the harms of trans discrimination, with the hopes of combating unscientific opposition.

98
article thumbnail

Gene therapy approved for Duchenne muscular dystrophy

European Pharmaceutical Review

The first gene therapy has been approved for certain patients from four to five years old with Duchenne muscular dystrophy (DMD). Elevidys has been authorised by the US Food and Drug Administration (FDA) for individuals with a confirmed mutation in the DMD gene without a pre-existing medical reason preventing treatment with this therapy. “Today’s approval addresses an urgent unmet medical need and is an important advancement in the treatment of Duchenne muscular dystrophy,” reported Dr Peter M

FDA 98
article thumbnail

Zeiss Vision Care intros Warm Eye Masks

Drug Store News

Zeiss Warm Eye Masks can be a solution for dry eyes, excessive screen use, airborne pollution or air conditioning, the company said.

98
article thumbnail

STAT+: At a defunct power station, the U.K. and Moderna celebrate a partnership meant to be an engine for science

STAT

LONDON — Back in the 1950s, Battersea Power Station, a towering brick structure on the south bank of the Thames, supplied a fifth of London’s electricity, an economic engine that even powered Buckingham Palace. The coal-fired plant was decommissioned decades ago. But on Thursday evening, in an art deco, gold-and-glass control room in the recently retrofitted power station — now a multi-use development complete with apartments and a cinema — the U.K. government and the

98
article thumbnail

ASCO 2023 – Warner Biddle

pharmaphorum

ASCO 2023 – Warner Biddle Mike.

98
article thumbnail

JCVI backs RSV routine vaccination for babies and older adults in the UK

Hospital Pharmacy Europe

The UK should introduce routine vaccination for respiratory syncytial virus (RSV) to protect babies and older adults, the Joint Committee on Vaccination and Immunisation (JCVI) has recommended. It has made the early recommendations after reviewing several vaccines currently in development to allow sufficient lead time for the Government to get a policy and programme in place, a statement said.

article thumbnail

Intercept changes course as OCA is rejected for NASH again

pharmaphorum

Intercept changes course as OCA is rejected for NASH again Phil.

98
article thumbnail

STAT+: EU poised to reject Amylyx’s ALS drug, as the company vows an appeal

STAT

LONDON — European regulators are on the verge of rejecting an ALS drug from Amylyx Pharmaceuticals, all but dooming the medicine’s chances of entering the E.U. market for now. The negative recommendation issued Friday by a European Medicines Agency committee is not a surprise. Last month, Amylyx said that the agency was headed toward a negative review.

98
article thumbnail

Clover Health settles lawsuits alleging that it hid a federal probe from investors

Fierce Healthcare

Clover Health has reached a settlement in lawsuits alleging that the Medicare Advantage insurtech had not been forthright with investors when the company went public, the company announced in a

98